Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 122,470,452
- Total 13F shares
- 100,610,243
- Share change
- +585,565
- Total reported value
- $1,368,169,306
- Put/Call ratio
- 4.4%
- Price per share
- $13.60
- Number of holders
- 186
- Value change
- +$17,470,409
- Number of buys
- 92
- Number of sells
- 85
Quarterly Holders Quick Answers
What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969F109:
Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. |
3/4/5
13F
|
10%+ Owner · Company |
26%
from 13F
|
31,424,760
|
$345,672,360 | — | 18 Feb 2025 | |
| BlackRock, Inc. |
13F
|
Company |
9.4%
|
11,457,979
|
$93,267,949 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13D/G
13F
|
Company |
4.1%
|
4,332,479
|
$58,921,714 | -$20,381,232 | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.4%
|
6,556,243
|
$53,367,818 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
3.3%
|
4,000,029
|
$32,560,236 | — | 30 Jun 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3%
|
3,688,858
|
$30,027,304 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
3,630,815
|
$29,554,834 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
2.1%
|
2,573,294
|
$20,946,615 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
1,659,879
|
$13,510,521 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
1.3%
|
1,612,077
|
$13,122,307 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,596,329
|
$12,994,975 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
1,469,804
|
$11,964,205 | — | 30 Jun 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.1%
|
1,395,726
|
$11,362,000 | — | 30 Jun 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.99%
|
1,216,016
|
$9,898,370 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.93%
|
1,136,364
|
$9,250,003 | — | 30 Jun 2025 | |
| Yasunori Kaneko |
3/4/5
|
Director |
—
mixed-class rows
|
990,555
mixed-class rows
|
$7,732,309 | — | 10 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.76%
|
936,021
|
$7,619,212 | — | 30 Jun 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.66%
|
805,305
|
$6,555,183 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.64%
|
780,088
|
$6,349,916 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.63%
|
776,742
|
$6,322,680 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
691,247
|
$5,626,751 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.53%
|
648,074
|
$5,275,322 | — | 30 Jun 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.51%
|
627,626
|
$5,108,876 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.5%
|
611,195
|
$4,975,127 | — | 30 Jun 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.49%
|
599,610
|
$4,880,825 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.41%
|
497,619
|
$4,050,619 | — | 30 Jun 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.4%
|
490,613
|
$3,993,590 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.4%
|
484,053
|
$3,940,192 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.39%
|
482,089
|
$3,924,204 | — | 30 Jun 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.35%
|
430,000
|
$3,500,200 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.33%
|
408,195
|
$3,322,707 | — | 30 Jun 2025 | |
| PDT Partners, LLC |
13F
|
Company |
0.32%
|
389,287
|
$3,168,796 | — | 30 Jun 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.31%
|
379,100
|
$3,086,000 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.3%
|
368,100
|
$2,996,334 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.28%
|
348,460
|
$2,836,464 | — | 30 Jun 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.27%
|
336,225
|
$2,736,871 | — | 30 Jun 2025 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.26%
|
319,899
|
$2,632,768 | — | 30 Jun 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.24%
|
300,000
|
$2,442,000 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.24%
|
295,800
|
$2,407,812 | — | 30 Jun 2025 | |
| DARK FOREST CAPITAL MANAGEMENT LP |
13F
|
Company |
0.23%
|
282,671
|
$2,300,942 | — | 30 Jun 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.21%
|
258,937
|
$2,107,747 | — | 30 Jun 2025 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.21%
|
257,270
|
$2,094,178 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.21%
|
251,851
|
$2,050,067 | — | 30 Jun 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.2%
|
247,966
|
$2,018,443 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.2%
|
246,670
|
$2,007,894 | — | 30 Jun 2025 | |
| AXA S.A. |
13F
|
Company |
0.19%
|
231,978
|
$1,888,301 | — | 30 Jun 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.19%
|
231,024
|
$1,880,535 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.19%
|
229,298
|
$1,866,485 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.18%
|
226,337
|
$1,842,382 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.17%
|
210,355
|
$1,712,260 | — | 30 Jun 2025 |
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q3 2025
As of 30 Sep 2025,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
186 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,610,243 shares.
The largest 10 holders included
GILEAD SCIENCES, INC., BlackRock, Inc., VANGUARD GROUP INC, Point72 Asset Management, L.P., Woodline Partners LP, SUVRETTA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Siren, L.L.C., FMR LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
186
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
181
Q3 2025 holders
186
Holder diff
5
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.